EUVIMEDEUVIMED entdecken
Crossref

EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN

A. A. Ruleva, S. M. Kharit, E. P. Nacharova, I. V. Fridman

Pediatric pharmacology · 2013

DOI: 10.15690/pf.v10i1.591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric pharmacology, 2013. Verfasst von A. A. Ruleva und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ruleva, A. A., Kharit, S. M., Nacharova, E. P., & Fridman, I. V. (2013). EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN. Pediatric pharmacology. https://doi.org/10.15690/pf.v10i1.591

Vancouver

Ruleva AA, Kharit SM, Nacharova EP, Fridman IV. EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN. Pediatric pharmacology. 2013. doi:10.15690/pf.v10i1.591

BibTeX
@article{Ruleva2013,
  author = {Ruleva, A. A. and Kharit, S. M. and Nacharova, E. P. and Fridman, I. V.},
  title = {EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN},
  journal = {Pediatric pharmacology},
  year = {2013},
  doi = {10.15690/pf.v10i1.591}
}
Kostenlos starten →